P5 Research to improve monitoring and evaluation of immunization programs

P6 Protection of pregnant women, neonates and infants by maternal immunization

P7 Innovative vaccine research: the point of view of industry and biotech companies

W1 Towards the Development of a Universal Influenza Vaccine

W2 Preferred Product Characteristics (PPC) as a Way to Guide Development of Products of High Public Health Utility

W4 How to Optimize Immunization Coverage? A case study from Measles-Rubella vaccination

W7 Contributions of Regulatory Science to Vaccine Access

W8 Systems Vaccinology

KN1.3 GVIRF Overview and Goals

KN1.4 What do we expect from the meeting?

KN2.1 WHO Director-General address to GVIRF

KN2.2 Perspectives on Vaccines and Poverty Reduction

KN3-1 The Importance of Innovation in Addressing Global Health Gaps in the Developing World

P1a.1 Status of HIV Vaccine Research & Development

P1a.2 Progress towards the development of an HIV vaccine: Discussion

P1b.1 Update on Tuberculosis Vaccines - 2014

P1b.2 TB Vaccine Development: Challenges & Opportunities

P1c.1 Progress towards the development of a malaria vaccine

P1c.2 Progress towards the development of a malaria vaccine: discussion

P2.1 Regulatory and public health challenges

P2.2 Regulatory Considerations for Determining Vaccine Efficacy

P3.1 Developing next generation vaccines: Introduction

P3.2 Developing Country Vaccine Manufacturers - Access to Immunization

P3.3 Developing Next Generation Rotavirus Vaccines: Prospects from the Pipeline to Address Remaining Public Health Needs

P3.4 Evaluation of the Next Generation of Rotavirus Vaccines

P5.1 Immunization Registries in Latin America and the Caribbean

P5.2 Influenza Vaccine Use in the Americas: Network for Evaluation of Influenza Vaccine Effectiveness REVELAC-1

P6.1 Public Health Benefits of Maternal Immunization

P6.2 Maternal Immunization: which impact on infant immunity?

P7.1 Innovation for vaccines against poverty diseases: the need for new support mechanisms

W1.1 Towards the Development of a Universal Influenza Vaccine

W2.1 WHO Preferred Product Characteristics: Bridging Vaccine R&D with Public Health

W2.2 RSV Vaccine Development for Low and Middle Income Countries: Challenges and Progress

W2.3 Group A streptococcal vaccines: Challenges and progress

W3.1 Leishmania Vaccine Development: Progress and challenges in the context of other control strategies

W3.2 Pre-exposure rabies vaccination (PreP) in children of endemic countries

W4.1 Progress, Challenges, and Lessons Learned in Achieving Measles and Rubella Goals

W4.2 Prioritizing the Research Agenda for Measles and Rubella

W5.1 Immunization implementation research priority setting

W5.2 Factors influencing community health volunteers in participating in health programs in Africa

W5.3 Strengthening national capacity for evidence-based immunization policy: the case of program costing in Honduras

W5.4 Building Implementation Research Capacity for Polio Eradication

W6.1 WHO - Next-generation Vaccine Delivery Technology Meeting Summary

W6.2 Beyond the cold chain… Meningitis A conjugate vaccine in a controlled temperature chain: Experience from Benin

W6.3 Case Study: The Uniject Injection System

W7.1 Contributions of Regulatory Science to Vaccine Access

W7.2 Enhancement in Laboratory Research to Support Innovations in Regulatory Science for the Evaluation of New Vaccines

W7.3 How can innovation in regulatory science inform the regulatory process to facilitate the development of new vaccines?

W8.1 How can recent technological advances in systems vaccinology accelerate next-generation vaccine development?

W8.2 Systems Vaccinology

W8.3 Application of technological advances to clinical trials

P8 General Conclusion

*Global Vaccine and Immunization Research Forum: Opportunities and challenges in vaccine discovery, development, and delivery

KN1.2 R&D in the "Decade of Vaccines"

KN1 Opening Session and Keynote

KN1.1 Vaccine Research and Development: Challenges and Opportunities

P1c Develop New and Improved Vaccines - Malaria

P1b Develop New and Improved Vaccines - TB